glp 1 drugs and crohn's disease Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, therapeutic potential ADJUNCTIVE GLP-1 RECEPTOR AGONISTS IN
Description
Oxyntomodulin analogue increases energy expenditure via the Gcg receptor
Therefore, GLP-1R agonists may be new and promising treatment alternatives for obese subjects
Non-alcoholic fatty liver disease (NAFLD) can progress to NASH, a major risk factor for liver cancer [95]
Wan J, Ferrari C, Tadros M
